Tags:DrugPharmacyProductPublic
Chiasma is a clinical-stage biopharmaceutical company dedicated to addressing the everyday challenges associated with existing therapies for rare or serious chronic diseases.
Location: United States, Massachusetts, Waltham
Total raised: $164.5M

Investors 4

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
27.02.2015Series E$70M-vcnewsdail...
29.12.2014-$56M-fiercebiot...
23.07.2012Series D$38.5M-finsmes.co...

Mentions in press and media 9

DateTitleDescriptionCategoryAuthorSource
26.07.2019Chiasma An...---mpmcapital...
04.10.2016Sam­sung B...In the lat­est ad­vance by a n...-John Carro...endpts.com...
02.03.2015Chiasma Co... NEWTON, MA, Privately-held b...--vcnewsdail...
27.02.2015Chiasma Cl...Chiasma, Inc., a U.S. privatel...Israel US...-finsmes.co...
27.02.2015Chiasma An...---mpmcapital...
02.01.2015With Roche...In early 2013, Roche ($RHHBY) ...Venture Ca...-fiercebiot...
29.12.2014Despite Ro...Roche initially held a $595 mi...--medcitynew...
23.07.2012Chiasma Cl...Chiasma, Inc., a Jerusalem, Is...funding I...-finsmes.co...
-Despite Ro...Israeli startup Chiasma in the...--medcitynew...